Rongpu Liang

654 total citations
17 papers, 455 citations indexed

About

Rongpu Liang is a scholar working on Oncology, Immunology and Biomedical Engineering. According to data from OpenAlex, Rongpu Liang has authored 17 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Immunology and 5 papers in Biomedical Engineering. Recurrent topics in Rongpu Liang's work include Cancer Immunotherapy and Biomarkers (7 papers), Nanoplatforms for cancer theranostics (5 papers) and Immune Cell Function and Interaction (4 papers). Rongpu Liang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Nanoplatforms for cancer theranostics (5 papers) and Immune Cell Function and Interaction (4 papers). Rongpu Liang collaborates with scholars based in China, Uzbekistan and Belarus. Rongpu Liang's co-authors include Dongbing Ding, Bo Wei, Jun Shao, Xudong Zhu, Shengxin Huang, Xintao Shuai, Huihai Zhong, Hongbo Wei, Zongheng Zheng and Tufeng Chen and has published in prestigious journals such as Journal of Controlled Release, Acta Biomaterialia and Advanced Science.

In The Last Decade

Rongpu Liang

14 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rongpu Liang China	11	179	164	145	105	97	17	455
Dongbing Ding China	12	210 1.2×	179 1.1×	140 1.0×	147 1.4×	92 0.9×	20	509
Shengxin Huang China	11	116 0.6×	92 0.6×	165 1.1×	115 1.1×	65 0.7×	17	439
Jingyao Tu China	13	142 0.8×	177 1.1×	108 0.7×	182 1.7×	100 1.0×	27	466
Lihua Qiu China	15	163 0.9×	246 1.5×	143 1.0×	183 1.7×	103 1.1×	71	640
Shiyi Shao China	11	78 0.4×	68 0.4×	137 0.9×	142 1.4×	54 0.6×	18	329
Bingqiang Gao China	10	64 0.4×	69 0.4×	97 0.7×	137 1.3×	78 0.8×	21	401
Zhenmei Yang China	12	141 0.8×	129 0.8×	126 0.9×	126 1.2×	37 0.4×	14	391
Jared M. Newton United States	12	140 0.8×	184 1.1×	97 0.7×	166 1.6×	54 0.6×	19	424
Chih-Chun Chang Taiwan	8	149 0.8×	100 0.6×	147 1.0×	123 1.2×	28 0.3×	14	429
Zhaoze Guo China	12	83 0.5×	148 0.9×	136 0.9×	223 2.1×	72 0.7×	28	497

Countries citing papers authored by Rongpu Liang

Since Specialization

Citations

This map shows the geographic impact of Rongpu Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongpu Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongpu Liang more than expected).

Fields of papers citing papers by Rongpu Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongpu Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongpu Liang. The network helps show where Rongpu Liang may publish in the future.

Co-authorship network of co-authors of Rongpu Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Rongpu Liang. A scholar is included among the top collaborators of Rongpu Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongpu Liang. Rongpu Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Liang, Rongpu, et al.. (2025). CD155 promotes the progression of colorectal cancer by restraining CD8+ T cells via the PI3K/AKT/NF-κB pathway. Cancer Immunology Immunotherapy. 74(3). 94–94.

Ren, Jiannan, Menglin Song, Dongbing Ding, et al.. (2025). Combined Oxaliplatin with 5-Fluorouracil for Effective Chemotherapy Against Gastric Cancer in Animal Model. International Journal of Nanomedicine. Volume 20. 7763–7780.

Ding, Dongbing, Jiannan Ren, Rongpu Liang, et al.. (2025). SPP1 ^high macrophage-induced T-cell stress promotes colon cancer liver metastasis through SPP1/CD44/PI3K/AKT signaling. Journal for ImmunoTherapy of Cancer. 13(10). e012330–e012330.

Liang, Rongpu, Dongbing Ding, Shengxin Huang, et al.. (2024). HDACi combination therapy with IDO1i remodels the tumor microenvironment and boosts antitumor efficacy in colorectal cancer with microsatellite stability. Journal of Nanobiotechnology. 22(1). 753–753. 5 indexed citations

Ding, Dongbing, Rongpu Liang, Shengxin Huang, et al.. (2024). Nanodrug modified with engineered cell membrane targets CDKs to activate aPD-L1 immunotherapy against liver metastasis of immune-desert colon cancer. Journal of Controlled Release. 369. 309–324. 10 indexed citations

Huang, Shengxin, Dongbing Ding, Jiannan Ren, et al.. (2023). Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis. Acta Biomaterialia. 164. 538–552. 42 indexed citations

Shao, Jun, Wende Yang, Rui Guo, et al.. (2022). An EPO ‐loaded multifunctional hydrogel synergizing with adipose‐derived stem cells restores neurogenic erectile function via enhancing nerve regeneration and penile rehabilitation. Bioengineering & Translational Medicine. 7(3). e10319–e10319. 20 indexed citations

Zhu, Xudong, Rongpu Liang, Dongbing Ding, et al.. (2022). Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer. Journal for ImmunoTherapy of Cancer. 10(9). e004219–e004219. 87 indexed citations

Li, Wenjuan, Rui Zheng, Xiaofeng Yang, et al.. (2021). Chest CT Features from 58 Patients with COVID-19 Pneumonia from the Perspective of ACE2. Clinical Laboratory. 67(09/2021). 1 indexed citations

10.

Liang, Rongpu, Xudong Zhu, Dongbing Ding, et al.. (2021). TIGIT promotes CD8+T cells exhaustion and predicts poor prognosis of colorectal cancer. Cancer Immunology Immunotherapy. 70(10). 2781–2793. 54 indexed citations

11.

Ding, Dongbing, Huihai Zhong, Rongpu Liang, et al.. (2021). Multifunctional Nanodrug Mediates Synergistic Photodynamic Therapy and MDSCs‐Targeting Immunotherapy of Colon Cancer. Advanced Science. 8(14). e2100712–e2100712. 91 indexed citations

12.

Shao, Jun, Rongpu Liang, Dongbing Ding, et al.. (2021). A Smart Multifunctional Nanoparticle for Enhanced Near-Infrared Image-Guided Photothermal Therapy Against Gastric Cancer. International Journal of Nanomedicine. Volume 16. 2897–2915. 43 indexed citations

13.

Li, Wenjuan, Rui Zheng, Rongpu Liang, et al.. (2021). Effects of Smoking on ACE2 Expression Pattern: Risk and Severity of SARS-CoV-2 Infection. Clinical Laboratory. 67(07/2021). 2 indexed citations

14.

Shao, Jun, Xiaoming Zheng, Longbao Feng, et al.. (2020). Targeting Fluorescence Imaging of RGD-Modified Indocyanine Green Micelles on Gastric Cancer. Frontiers in Bioengineering and Biotechnology. 8. 575365–575365. 20 indexed citations

15.

Liang, Chenghua, Nan Li, Rongpu Liang, et al.. (2019). Co-encapsulation of magnetic Fe ₃ O ₄ nanoparticles and doxorubicin into biocompatible PLGA-PEG nanocarriers for early detection and treatment of tumours. Artificial Cells Nanomedicine and Biotechnology. 47(1). 4211–4221. 23 indexed citations

16.

Ye, Linsen, Rongpu Liang, Jiebin Zhang, et al.. (2019). Postoperative albumin-bilirubin grade and albumin-bilirubin change predict the outcomes of hepatocellular carcinoma after hepatectomy. Annals of Translational Medicine. 7(16). 367–367. 22 indexed citations

17.

Ye, Linsen, Yang Li, Hui Tang, et al.. (2019). CD8+CXCR5+T cells infiltrating hepatocellular carcinomas are activated and predictive of a better prognosis. Aging. 11(20). 8879–8891. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact